Skip to main content

FDA approves IL-23 inhibitor risankizumab for treating plaque psoriasis

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
FDA approves IL-23 inhibitor risankizumab for treating plaque psoriasis

User login

Username

Password

Reset your password

Type	Lead	score